The role of the nervous system in the regulation of liver cytochrome P450

Current Drug Metabolism

Volumn 12, Issue 2, 2011, Pages 124-138

  Wójcikowski, Jacek ^a   Daniel, Wladyslawa Anna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Autonomic nervous system; Brain; Cytokines; Dopaminergic system; Liver cytochrome P450; Noradrenergic system; Pituitary hormones; Serotonergic system

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ACETYLCHOLINE; ADRENALIN; AMPHETAMINE; ANTIDEPRESSANT AGENT; APOMORPHINE; CORTICOTROPIN; CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 2B; CYTOCHROME P450 2C11; CYTOCHROME P450 3A; CYTOKINE; DOPAMINE; DOPAMINE 2 RECEPTOR; GROWTH HORMONE; NEUROTOXIN; NORADRENALIN; PHENOTHIAZINE; PSYCHOTROPIC AGENT; QUINPIROLE; SEROTONIN; SEX HORMONE; THYROID HORMONE; THYROTROPIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CENTRAL NERVOUS SYSTEM; DRUG BINDING; DRUG MECHANISM; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME REGULATION; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREGULATION; LIVER FUNCTION; MESOLIMBIC DOPAMINERGIC SYSTEM; MONOAMINERGIC SYSTEM; NERVOUS SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PERIPHERAL NERVOUS SYSTEM; PROTEIN EXPRESSION; SEROTONINERGIC SYSTEM;

ANIMALS; BIOGENIC MONOAMINES; CENTRAL NERVOUS SYSTEM; CYTOCHROME P-450 ENZYME SYSTEM; CYTOKINES; GONADAL STEROID HORMONES; GROWTH HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIVER; MODELS, NEUROLOGICAL; PERIPHERAL NERVOUS SYSTEM; PITUITARY HORMONES; PITUITARY-ADRENAL SYSTEM; PSYCHOTROPIC DRUGS; THYROID HORMONES;

EID: 79952776365     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920011795016908     Document Type: Article

References (179)

1. Honkakoski, P.; Negishi, M. Regulation of cytochrome P450 genes by nuclear receptors. Biochem. J., 2000, 347, 321-337. (Pubitemid 30229378)
2. Hines, R.N.; Luo, T.; Cresteil, T.; Ding, R.; Prough, R.A.; Fitzpatrick, J.L.; Ripp, S.L.; Falkner, K.C.; Ge, N.L., Lenine, A.; Elferink, C.J. Molecular regulation of genes encoding xenobioticmetabolizing enzymes: Mechanisms involving endogenous factors. Drug Metab. Dispos., 2001, 29, 623-633. (Pubitemid 32374561)
3. Wójcikowski, J. Potential role of the brain dopaminergic system in the regulation of cytochrome P450 expression. Pol. J. Pharmacol., 2004, 56, 701-708. (Pubitemid 40287471)
4. Kretschmer, X.C.; Baldwin, W.S. CAR and PXR: Xenosensors of endocrine disrupters? Chem. Biol. Interact., 2005, 155, 11-128.
5. Pascussi, J.M.; Gerbal-Chaloin, S.; Duret, C.; Daujat-Chavanieu, M.; Vilarem, M.J.; Maurel, P. The tangle of nuclear receptors that controls xenobiotic metabolism and transport: Crosstalk and consequences. Annu. Rev. Pharmacol. Toxicol., 2008, 48, 1-32. (Pubitemid 351738147)
6. Sonderfan, A.J.; Arlotto, M.P.; Dutton, D.R.; McMillen, S.K.; Parkinson, A. Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch. Biochem. Biophys., 1987, 255, 27-41.
7. Waxman, D.J. Interactions of hepatic cytochromes P450 with steroid hormones. Biochem. Pharmacol., 1988, 37, 71-84.
8. Wolterboer, H.M.; De Kruif, C.A.; van Iersel, A.A.J.; Falke, H.E.; Nordhoek, J.; Blaauboer, B.J. Comparison of cytochrome P-450 isoenzyme profiles in rat liver and hepatocyte cultures. Biochem. Pharmacol., 1991, 42, 381-390.
9. Chinta, S.J.; Andersen, J.K. Dopaminergic neurons. Int. J. Biochem. Cell Biol., 2005, 37, 942-946. (Pubitemid 40311737)
10. Oades, R.D.; Halliday, G.M. Ventral tegmental (A10) system: Neurobiology. 1. Anatomy and connectivity. Brain Res. Rev., 1987, 12, 117-165. (Pubitemid 17064083)
11. Goudreau, J.L.; Falls, W.M.; Lookingland, K.J.; Moore, K.E. Periventricular-hypophysial dopaminergic neurons innervate the in termediate but not the neural lobe of the rat pituitary gland. Neuroendocrinology, 1995, 62, 147-154.
12. Palkovits, M.; Leranth, C.; Zaborszky, L.; Brownstein, M.J. Electron microscopic evidence of direct neuronal connection from the lower brain stem to the median eminence. Brain Res., 1977, 136, 339-344. (Pubitemid 8205708)
13. Simon, H.; Le Moal, M.; Calas, A. Efferents and afferents of the ventral tegmental-A10 region studied after local injection of [3H] leucine and horseradish peroxidase. Brain Res., 1979, 178, 17-40. (Pubitemid 10241289)
14. Conrad, L.C.A.; Pfaff, D.W. Autoradiographic tracing of nucleus accumbens efferents in the rat. Brain Res., 1976, 133, 589-596.
15. Powell, E.W.; Leman, R.B. Connections of the nucleus accumbens. Brain Res., 1976, 105, 389-403.
16. Williams, D.J.; Crossman, A.R.; Slater, P. The efferent projections of the nucleus accumbens in the rat. Brain Res., 1977, 130, 217-227. (Pubitemid 8139720)
17. Hokfelt, T.; Fuxe, K.; Johansson, O.; Jeffcoate, S.; White, N. Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry. Eur. J. Pharmacol., 1975, 134, 389-392.
18. Sawchenko, P.E. Evidence for differential regulation of corticotropin- releasing factor and vasopressin immunoreactivities in parvocellular neurosecretory and autonomic-related projections of the paraventricular nucleus. Brain Res., 1987, 437, 253-263. (Pubitemid 18016213)
19. Seeman, P.; van Tol, H.H.M. Dopamine receptor pharmacology. Trends Pharmacol. Sci., 1994, 15, 264-267.
20. Boyson, S.J.; McGonigle, P.; Molinoff, P.B. Quantitative autoradiographic localization of D1 and D2 subtypes of dopamine receptors in rat brain. J. Neurosci., 1986, 6, 3177-3188. (Pubitemid 17186043)
21. Meador-Woodruff, J.H.; Mansour, A.; Healy, D.J.; Kuehn, R.; Zhou, Q.Y.; Bunzow, J.R.; Akil, H.; Civelli, O.; Watson, S.J. Jr. Comparison of the distributions of D1 and D2 dopamine receptors mRNAs in rat brain. Neuropsychopharmacology, 1991, 5, 231-242.
22. De Souza, E.B. Serotonin and dopamine receptors in the rat pituitary gland: Autoradiographic identification, characterization, and localization. Endocrinology, 1986, 119, 1534-1542. (Pubitemid 17170517)
23. Wamsley, J.K.; Gehlert, D.R.; Filloux, F.M.; Dawson, T.M. Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain. J. Chem. Neuroanat., 1989, 2, 119-137. (Pubitemid 19157683)
24. Levant, B.; Grigoriadis, D.E.; De Souza, E.B. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: A quantitative autoradiographic study. J. Pharmacol. Exp. Ther., 1993, 264, 991-1001. (Pubitemid 24283568)
25. Al-Damluji, S. Adrenergic control of the secretion of anterior pituitary hormones. Baillieres Clin. Endocrinol. Metab., 1993, 7, 355-392. (Pubitemid 23138255)
26. Jørgensen, H. S. Studies on the neuroendocrine role of serotonin. Dan. Med. Bull., 2007, 54, 266-288. (Pubitemid 351890220)
27. Krulich, L. Central neurotransmitters and the secretion of prolactin, GH, LH and TSH. Annu. Rev. Physiol., 1979, 41, 603-615.
28. McMahon, C.D.; Radecliff, R.P.; Lookingland, K.J.; Tucker, H.A. Neuroregulation of growth hormone secretion in domestic animals. Domestic Animal Endocrinol., 2001, 20, 65-87. (Pubitemid 32411131)
29. Müller, E.E. Some aspects of the neurotransmitter control of anterior pituitary function. Pharmacol. Res., 1989, 21, 75-85. (Pubitemid 19107175)
30. Strobl, J.; Thomas, M.J. Human Growth hormone. Pharmacol Rev, 1994, 46, 1-34. (Pubitemid 24100617)
31. Weiner, R.I.; Ganong, W.F. Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiol. Rev., 1978, 58, 905-976. (Pubitemid 9081949)
32. Fuller, R.W.; Snoddy, H.D. Elevation of serum corticosterone concentrations in rats by pergolide and other dopamine agonists. Endocrinology, 1981, 109, 1026-1032. (Pubitemid 11008277)
33. Jeřova, D.; Jurcovicova, J.; Vigas, M.; Murgas, K.; Labrie, F. Increase in plasma ACTH after dopaminergic stimulation in rats. Psychopharmacology, 1985, 85, 201-203. (Pubitemid 15108868)
34. Fuller, R.W.; Snoddy, H.D.; Mason, N.R.; Clemens, J.A.; Bemis, K.G. Elevation of serum corticosterone in rats by dopamine agonists related in structure to pergolide. Neuroendocrinology, 1983, 36, 285-290. (Pubitemid 13114615)
35. Jeřova, D.; Vigas, M. Apomorphine injection stimulates ř- endorphin, adrenocorticotropin, and cortisol release in healthy man. Psychoneuroendocrinology, 1988, 13, 479-485. (Pubitemid 19059360)
36. Prough, R.A.; Linder, M.W.; Pinairen, J.A.; Xiao, G.H.; Falkner, K.C. Hormonal regulation of hepatic enzymes involved in foreign compound metabolism. FASEB J., 1996, 10, 1369-1377. (Pubitemid 26347871)
37. Quatrochi, L.C.; Guzelian, P.S. CYP3A regulation: From pharmacology to nuclear receptors. Drug Metab. Dispos., 2001, 29, 615-622. (Pubitemid 32374560)
38. Lal, S.; De La Vega, C.; Sourkes, T.L.; Friesen, H.G. Effect of apomorphine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone levels in human serum. J. Clin. Edocrinol. Metab., 1973, 37, 719-724.
39. Nair, N.P.; Lal, S.; Iskandar, H.I.; Etienne, P.; Wood, P.L.; Guyda, H. Effect of sulpiride, an atypical neuroleptic, on apomorphineinduced growth hormone secretion. Brain Res. Bull., 1982, 8, 587-591. (Pubitemid 13240599)
40. Sherman, G.P.; Kim, S.; Benjamin, F.; Kolodny, K.D. Effect of chlorpromazine on serum growth hormone concentration in man. N. Engl. J. Med., 1971, 284, 72.
41. Hanev, K.; Sasaki, A.; Yoshinaga, K. Evidence for endogenous dopaminergic control of GH release in man. Tohoku J. Exp. Med., 1981, 135, 103-108. (Pubitemid 12234435)
42. Müller, E.E.; Pecile, A.; Felici, M.; Cocchi, D. Norepinephrine and dopamine injection into lateral brain ventricle of the rat and growth hormone-releasing activity in the hypothalamus and plasma. Endocrinology, 1970, 86, 1376-1382.
43. Mueller, G.P.; Simpkins, J.; Meites, J.; Moore, K.E. Differential effects of dopamine agonists and haloperidol on the release of prolactin, thyroid stimulating hormone, growth hormone, and luteinizing hormone in rats. Neuroendocrinology, 1976, 20, 121-135.
44. Vijayan, E.; Krulich, L.; McCann, S.M. Catecholamic regulation of TSH and growth hormone release in ovariectomized and steroidprimed rats. Neuroendocrinology, 1978, 26, 174-185. (Pubitemid 8364062)
45. Onaya, T.; Hashizume, K. Effects of drugs that modify brain biogenic amine concentrations on thyroid activation induced by exposure to cold. Neuroendocrinology, 1976, 20, 47-52.
46. Männistö, P.T.; Mattila, J.; Kaakkola, S. Possible involvement of nigrostriatal dopamine system in the inhibition of thyrotropin secretion in the rat. Eur. J. Pharmacol., 1981, 76, 403-409. (Pubitemid 12253537)
47. Morley, J.E.; Brammer, G.L.; Sharp, B.; Yamada, T.; Yuwiler, A.; Hershman, J.M. Neurotransmitter control of hypothalamicpituitary- thyroid function in rats. Eur. J. Pharmacol., 1981, 70, 263-271. (Pubitemid 11149318)
48. Daftary, S.S.; Boudaba, C.; Tasker, J.G. Noradrenergic regulation of parvocellular neurons in the rat hypothalamic paraventricular nucleus. Neuroscience, 2000, 96, 743-751. (Pubitemid 30155738)
49. French, N. ř2-Adrenoceptors and I2 sites in the mammalian central nervous system. Pharm. Ther., 1995, 68, 175-208.
50. Conway, S.; Richardson, L.; Speciale, S.; Moherek, R.; Mauceri, H.; Krulich, L. Interaction between norepinephrine and serotonin in the neuroendocrine control of growth hormone release in the rat. Endocrinology, 1990, 126, 1022-1030. (Pubitemid 20079517)
51. Itoi, K.; Helmreich, D.L.; Lopez-Figueroa, M.O. Watson S.J. Differential regulation of corticotropin-releasing hormone and vasopressin gene transcription in the hypothalamus by norepinephrine. J. Neurosci., 1999, 19, 5464-5472. (Pubitemid 29300211)
52. Mezey, E.; Reisine, T.D.; Palkovits, M.; Brownstein, M.J.; Axelrod, J. Direct stimulation of beta 2-adrenergic receptors in rat anterior pituitary induces the release of adrenocorticotropin in vivo. Proc. Natl. Acad. Sci. USA, 1983, 80, 6728-3671.
53. Arnold, M.A.; Fernstrom, J.D. L-Tryptophan injection enhances pulsatile growth hormone secretion in the rat. Endocrinology, 1981, 108, 331-335. (Pubitemid 11212836)
54. Murakami, Y.; Kato, Y.; Kabayama, Y.; Tojo, K.; Inue, T.; Imura, H. Involvement of growth hormone (GH)-releasing factor in GH secretion induced by serotoninergic mechanisms in conscious rats. Endocrinology, 1986, 119, 1089-1092. (Pubitemid 16053705)
55. Mota, A.; Bento, A.; Peñalva, A.; Pombo, M.; Dieguez, C. Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion. J. Clin. Endocrinol. Metab., 1995, 80, 1973-1977.
56. Papageorgiou, A.; Denef, C. Stimulation of growth hormone release by 5-hydroxytryptamine (5-HT) in cultured rat anterior pituitary cell aggregates: Evidence for mediation by 5-HT2B, 5-HT7, 5- HT1B, and ketanserin-sensitive receptors. Endocrinology, 2007, 148, 4509-4522. (Pubitemid 47295695)
57. Smythe, G.A.; Bradshaw, J.E.; Cai, W.Y.; Symons, R.G. Hypothalamic serotoninergic stimulation of thyrotropin secretion and related brain-hormone and drug interactions in the rat. Endocrinology, 1982, 111, 1181-1191.
58. Abrahamson, B.J.; Wormald, P.J.; Millar, R.P. Neuroendocrine regulation of thyrotropin release in cultured human pituitary cells. J. Clin. Endocrinol. Metab., 1987, 65, 1159-1163. (Pubitemid 18026851)
59. Raap, D.K.; Van de Kar, L.D. Selective serotonin reuptake inhibitors and neuroendocrine function. Life Sci., 1999, 65, 1217-1235. (Pubitemid 29425959)
60. Schüle, C. Neuroendocrinological mechanisms of actions of antidepressant drugs. J. Neuroendocrinology, 2007, 19, 213-226. (Pubitemid 46210949)
61. Schuetz, E.G.; Wrighton, S.A.; Barwick, J.L.; Guzelian, P.S. Induction of cytochrome P450 by glucocorticoids in rat liver. J. Biol. Chem., 1984, 259, 1999-2006.
62. Dvorak, Z.; Pavek, P. Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids. Drug Metab. Rev., 2010, 42, 621-635.
63. Monostory, K.; Pascussi, J.M.; Kóbori, L.; Dvorak, Z. Hormonal regulation of CYP1A expression. Drug Metab. Rev., 2009, 547-572.
64. Monostory, K.; Kohalmy, K.; Prough, R.A.; Kóbori, L.; Vereczkey, L. The effect of synthetic glucocorticoid, dexamethasone on CYP1A1 inducibility in adult rat and human hepatocytes. FEBS Lett., 2005, 579, 229-235. (Pubitemid 40023401)
65. Vrzal, R.; Stejskalova, L.; Monostory, K.; Maurel, P.; Bachleda, P.; Pavek, P.; Dvorak, Z. Dexamethasone controls aryl hydrocarbon receptor (AhR)-mediated CYP1A1 and CYP1A2 expression and activity in primary cultures of human hepatocytes. Chem. Biol. Interact., 2009, 179, 288-296.
66. Vrzal, R.; Daujat-Chavanieu, M.; Pascussi, J.M.; Ulrichova, J.; Maurel, P.; Dvorak, Z. Microtubules-interfering agents restrict aryl hydrocarbon receptor-mediated CYP1A2 induction in primary cultures of human hepatocytes via c-jun-N-terminal kinase and glucocorticoid receptor. Eur. J. Pharmacol., 2008, 581, 244-254.
67. Nishimura, M.; Koeda, A.; Suganuma, Y.; Suzuki, E.; Shimizu, T.; Nakayama, M.; Satoh, T.; Narimatsu, S.; Naito, S. Comparison of inducilibity of CYP1A and CYP3A mRNAs by prototypical inducers in primary cultures of human, cynomolgus monkey, and rat hepatocytes. Drug Metab. Pharmacokinet., 2007, 22, 178-186.
68. Bergeron, R.M.; Serron, S.C.; Rinehart, J.J.; Cawley, G.F.; Backes, W.L. Pituitary component of the aromatic hydrocarbon-mediated expression of CYP2B and CYP2C11. Xenobiotica, 1988, 28, 303-312.
69. Gibson, G.G.; Plant, N.J.; Swales, K.; Ayrton, A.; El-Sankary, W. Receptor-dependent transcriptional activation of cytochrome P4503A genes: Induction mechanisms, species differences and interindividual variation in man. Xenobiotica, 2002, 32, 165-206. (Pubitemid 34267348)
70. Dvorak, Z.; Modriansky, M.; Pichard-Garcia, L.; Balaguer, P.; Vilarem, M.J.; Ulrichova, J.; Maurel, P.; Pascussi, J.M. Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9 and 3A4 in human hepatocytes by affecting their glucocorticoid receptormediated regulation. Mol. Pharmacol., 2003, 64, 160-169. (Pubitemid 36759828)
71. Pascussi, J.M.; Gerbal-Chaloin, S.; Drocourt, L.; Fabre, J.M.; Maurel, P.; Vilarem, M.J. The expression of CYP2B6, CYP2C9 and CYP3A4 genes: A tangle of networks of nuclear and steroid receptors. Biochim. Biophys. Acta, 2003, 1619, 243-253. (Pubitemid 36163419)
72. Burk, O.; Wojnowski, L. Cytochrome P450 3A and their regulation. Naunyn-Schmieeberg's Arch. Pharmacol., 2004, 369, 105-124. (Pubitemid 38161227)
73. Pascussi, J.M.; Gerbal-Chaloin, S.; Drocourt, L.; Assenat, E.; Larrey, D.; Pichard-Garcia, L.; Vilarem, M.J.; Maurel, P. Crosstalk between xenobiotic detoxication and other signaling pathways: Clinical and toxicological consequences. Xenobiotica, 2004, 34, 633-664. (Pubitemid 39486045)
74. Onica, T.; Nichols, K.; Larin, M.; Ng, L.; Maslen, A.; Dvorak, Z.; Pascussi, J.M.; Vilarem, M.J.; Maurel, P.; Kirby, G.M. Dexamethasone- mediated up-regulation of human CYP2A6 involves the glucocorticoid receptor and increased binding of hepatic nuclear factor 4 alpha to the proximal promoter. Mol. Pharmacol., 2008, 73, 451-460. (Pubitemid 351159215)
75. Pascussi, J.M.; Drocourt, L.; Fabre, J.M.; Maurel, P.; Vilarem, M.J. Dexamethasone induces pregnane X receptor and retinoid X receptor- ř expression in human hepatocytes: Synergistic increase of CYP3A4 induction by pregnane X receptor. Mol. Pharmacol., 2000, 58, 361-372. (Pubitemid 30497480)
76. Pascussi, J.M.; Gerbal-Chaloin, S.; Fabre, J.M.; Maurel, P.; Vilarem, M.J. Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: Consequences on cytochrome P450 gene regulation. Mol. Pharmacol., 2000, 58, 1441-1450.
77. Hukkanen, J.; Lassila, A.; Paivarinta, K.; Valanne, S.; Sarpo, S.; Hakkola, J.; Pelkonen, O.; Raunio, H. Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line. Am. J. Respir. Cell Mol. Biol., 2000, 22, 360-366. (Pubitemid 30343363)
78. Hukkanen, J.; Vaisanen, T.; Lassila, A.; Piipari, R.; Anttila, S.; Pelkonen, O.; Raunio, H.; Hakkola, J. Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells. J. Pharmacol. Exp. Ther., 2003, 304, 745-752. (Pubitemid 36152353)
79. Pereira, T.M.; Carlstedt-Duke, J.; Lechner, M.C.; Gustafsson, J.A. Identification of a functional glucocorticoid response element in the CYP3A1/igc2 gene. DNA Cell Biol., 1998, 17, 39-49. (Pubitemid 28084082)
80. Telhada, M.B.; Pereira, T.M.; Lechner, M.C. Effect of dexamethasone and Phenobarbital on run-on transcription rate and CYP3A mRNA concentration in rat liver: Changes during development. Arch. Biochem. Biophys., 1992, 298, 715-725.
81. Le Cluyse, E.L. Pregnane X receptor: Molecular basis for species differences in CYP3A induction by xenobiotics. Chem. Biol. Interact., 2001, 134, 283-289. (Pubitemid 32406150)
82. Jones, S.A.; Moore, L.B.; Shenk, J.L.; Wisely, G.B.; Hamilton, G.A.; McKee, D.D.; Tomkinson, N.C.O.; LeCluyse, E.L.; Lambert, M.H.; Willson, T.M.; Kliewer, S.A.; Moore, J.T. The pregnane X receptor: A promiscuous xenobiotic receptor that has diverged during evolution. Mol. Endocrinol., 2000, 14, 27-39. (Pubitemid 32260325)
83. Sinz, M.W.; Pray, D.; Raucy, J. The utility of stable cell lines to assess species differences in PXR transactivation. Drug Met. Lett., 2007, 1, 147-152.
84. Zaphiropoulos, P.G.; Mode, A.; Norstedt, G.; Gustafsson, J.A. Regulation of sexual differentiation in drug and steroid metabolism. TIPS, 1989, 10, 149-153. (Pubitemid 19106306)
85. Waxman, D.J.; Ram, P.A.; Pampori, N.A.; Shapiro, B.H. Growth hormone regulation of male-specific rat liver P450 2A2 and 3A2: Induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate. Mol. Pharmacol., 1995, 48, 790-797.
86. Waxman, D.J.; O'Connor, C. Growth hormone regulation of sexdependent liver gene expression. Mol. Endocrinol., 2006, 20, 2613-2629. (Pubitemid 44833525)
87. Legraverend, C.; Mode, A.; Westin, S.; Strom, A.; Eguchi, H.; Zaphiropoulos, P.G.; Gustafsson, J.A. Transcriptional regulation of rat P-450 2C gene subfamily members by the sexually dimorphic pattern of growth hormone secretion. Mol. Endocrinol., 1992, 6, 259-266.
88. Sundseth, S.S.; Alberta, J.A.; Waxman, D.J. Sex-specific, growth hormone-regulated transcription of the cytochrome P450 2C11 and 2C12 genes. J. Biol. Chem., 1992, 267, 3907-3914.
89. Pampori, N.A.; Shapiro, B.H. Feminization of hepatic cytochrome P450s by nominal levels of growth hormone in the feminine plasma profile. Mol. Pharmacol., 1996, 50, 1148-1156. (Pubitemid 26384853)
90. Shimada, M.; Murayama, N.; Nagata, K.; Hashimoto, H.; Yamazoe, Y. A specific loss of growth hormone abolished sex-dependent expression of hepatic cytochrome P450 in rats: Reversal of the profiles by growth hormone-treatment. Arch. Biochem. Biophys., 1997, 337, 34-42. (Pubitemid 27198052)
91. Pampori, N.A.; Agrawal, A.K.; Shapiro, B.H. Infusion of genderdependent plasma growth hormone profiles into intact rats: Effects of subcutaneous, intraperitoneal, and intravenous routes of rat and human growth hormone on endogenous circulating growth hormone profiles and expression of sexually dimorphic hepatic CYP isoforms. Drug Metab. Dispos., 2001, 29, 8-16. (Pubitemid 32042156)
92. Schuetz, E.G.; Schuetz, J.D.; May, B.; Guzelian, P.S. Regulation of cytochrome P-450b/e and P-450p gene expression by growth hor mone in adult rat hepatocytes cultured on a reconstituted basement membrane. J. Biol. Chem., 1990, 265, 1188-1192.
93. Liddle, C.; Mode, A.; Legraverend, C.; Gustafsson, J.A. Constitutive expression and hormonal regulation of male sexually differentiated cytochromes P450 in primary cultured rat hepatocytes. Arch. Biochem. Biophys., 1992, 298, 159-166.
94. Choi, H.K.; Waxman, D.J. Plasma growth hormone pulse activation of hepatic JAK-STAT5 signaling: Developmental regulation and role in male-specific liver gene expression. Endocrinology, 2000, 141, 3245-3255. (Pubitemid 32269012)
95. Gonzalez, F.J.; Lee, Y.H. Constitutive expression of hepatic cytochrome P-450 genes. FASEB J., 1996, 10, 1112-1117. (Pubitemid 26276953)
96. Jaffe, C.A.; Turgeon, D.K.; Lown, K.; Demott-Friberg, R.; Watkins, P.B. Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans. Am. J. Physiol. Endocrinol. Metab., 2002, 283, E1008-E1015. (Pubitemid 35216960)
97. Dhir, R.; Dworakowski, W.; Tangavel, C.; Shapiro, B.H. Sexual dimorphic regulation of hepatic isoforms of human cytochrome P450by growth hormone. J. Pharmacol. Exp. Ther., 2006, 316, 87-94. (Pubitemid 41832584)
98. Lamba, V.; Lamba, J.; Yasuda, K.; Strom, S.; Danila, J.; Hancock, M.L.; Fackenthal, J.D.; Rogan, P.K., Ring, B., Wrighton, S.A.; Schuetz, E.G. Hepatic CYP2B6 expression: Gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J. Pharmacol. Exp. Ther., 2003, 307, 906-922. (Pubitemid 37494207)
99. Swales, K.; Kakizaki, S.; Yamamoto, Y.; Inoue, K.; Kobayashi, K.; Negishi, M. Novel CAR-mediated mechanism for synergistic activation of two distinct elements within the human cytochrome P450 2B6 gene in HepG2 cells. J. Biol. Chem., 2005, 280, 3458-3466. (Pubitemid 40223810)
100. Devesa, J.; Barros, M.G.; Gondar, M.; Tresguerres, J.A.F.; Arce, V. Regulation of hypothalamic somatostatin by glucocorticoids. J. Steroid. Biochem. Molec. Biol., 1995, 53, 277-282.
101. Iber, H.; Chen, Q.; Sewer, M.; Morgan, E.T. Regulation of hepatic cytochrome P450 2C11 by glucocorticoids. Arch. Biochem. Biophys., 1997, 343, 305-310. (Pubitemid 27400624)
102. Miller, T.L.; Mayo, K.E. Glucocorticoids regulate pituitary growth hormone-releasing hormone receptor messenger ribonucleic acid expression. Endocrinology, 1997, 138, 2458-2465. (Pubitemid 27215250)
103. Ohyama, T.; Sato, M.; Ohye, H.; Murao, K.; Nimi, M.; Takahara, J. Effects of adrenalectomy and glucocorticoid receptor antagonist, RU38486, on pituitary growth hormone-releasing hormone receptor gene expression in rats. Peptides, 1998, 19, 1063-1067. (Pubitemid 28383804)
104. Gehlhaus, M.; Schmitt, N.; Volk, B.; Meyer, R.P. Antiepileptics drugs affect neuronal androgen signaling via a cytochrome P450- dependent pathway. J. Pharmacol. Exp. Ther., 2007, 322, 550-559. (Pubitemid 47105805)
105. Meyer, R.P.; Gehlhaus, M.; Schwab, R.; Bürck, C.; Knoth, R.; Hagemeyer, C.E. Concordant up-regulation of cytochrome P450 Cyp3a11, testosterone oxidation and androgen receptor expression in mouse brain after xenobiotic treatment. J. Neurochem., 2009, 109, 670-681.
106. Yamazoe, Y.; Murayama, N.; Shimada, M.; Kato, R. Thyroid hormone suppression of hepatic levels of phenobarbital-inducible P-450b and P-450e, and other neonatal P-450s in hypophysectomized rats. Biochem. Biophys. Res. Commun., 1989, 160, 609-614. (Pubitemid 19140583)
107. Waxman, D.J.; Ram, P.A.; Notani, G.; LeBlanc, G.A.; Alberta, J.A.; Morrissey, J.J.; Sundseth, S.S. Pituitary regulation of the male-specific steroid 6ř-hydroxylase P-450 2a (gene product IIIA2) in adult rat liver. Suppressive influence of growth hormone and thyroxine acting at a pretranslational level. Mol. Endocrinol., 1990, 4, 447-454.
108. Yamazoe, Y.; Ling, X.; Murayama, N.; Nagata, K.; Kato, R. Modulation of hepatic level of microsomal testosterone 7 alphahydroxylase, P-450a (P450IIA), by thyroid hormone and growth hormone in rat liver. J. Biochem., 1990, 108, 599-603. (Pubitemid 20336673)
109. Liddle, C.; Goodwin, B.J.; George, J.; Tapner, M.; Farrell, G. Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J. Clin. Endocrinol. Metab., 1998, 83, 2411-2416. (Pubitemid 28503039)
110. Ram, P.A.; Waxman, D.J. Pretranslational control by thyroid hormone of rat liver steroid 5 alpha-reductase and comparison to the thyroid dependence of two growth hormone-regulated CYP2C mRNAs. J. Biol. Chem., 1990, 265, 19223-19229.
111. Basu, S.; Dasgupta, P.S. Dopamine, a neurotransmitter, influences the immune system. J. Neuroimmunol., 2000, 102, 113-124.
112. Castano, A.; Herrera, A.J.; Cano, J.; Machado, A. The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh- TNF-alpha, IL-1beta and IFN-gamma. J. Neurochem., 2002, 81, 150-157. (Pubitemid 34808862)
113. Stypula, G.; Kunert-Radek, J.; Střpieř, H.; řyliřska, K.; Pawlikowski, M. Evaluation of interleukins, ACTH, cortisol and prolactin concentration in the blood of patients with Parkinson's disease. Neuroimmunomodulation, 1996, 3, 131-134. (Pubitemid 26373868)
114. Ganguli, R.; Yang, Z.W.; Shurin, G.; Chengappa, K.N.R.; Brar, J.S.; Gubbi, A.V.; Rabin, B.S. Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness. Psychiatry Res., 1994, 51, 1-10. (Pubitemid 24056866)
115. Maes, M.; Bosmans, E.; Calabrese, J.; Smith, R.; Meltzer, H.Y. Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers. J. Psychiatr. Res., 1995, 29, 141-152.
116. Jankovic, B.D.; Maric, D. In vivo modulation of immune system by encephalin. Int. J. Neurosci., 1990, 51, 167-169.
117. Matera, L. Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci., 1996, 59, 599-614. (Pubitemid 26274402)
118. Khan, Z.U.; Koulen, P.; Rubinstein, M.; Grandy, D.K.; Goldman- Rakic, P.S. An astroglia-linked dopamine D2-receptor action in prefrontal cortex. PNAS, 2001, 98, 1964-1969. (Pubitemid 32165606)
119. Voltera, A.; Meldolesi, J. Astrocytes, from brain glue to communication elements: The revolution continues. Nat. Rev. Neurosci., 2005, 6, 626-640. (Pubitemid 41059337)
120. Gutierrez, E.G.; Banks, W.A.; Kastin, A.J. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol., 1993, 47, 169-176. (Pubitemid 23284281)
121. Kubera, M.; Basta-Kaim, A.; Papp, M. The effect of chronic treatment with imipramine on the immunoreactivity of animals subjected to a chronic mild stress model of depression. Immunopharmacology, 1995, 30, 225-230.
122. Sřuřewska, A.; Rybakowski, J.K.; řaciak, M.; Mackiewicz, A.; Sobieska, M.; Wiktorowicz, K. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann. N. Y. Acad. Sci., 1995, 762, 474-476.
123. Leonard, B.E. The immune system, depression and the action of antidepressants. Prog. Neuro-Psychopharmacol. Biol. Psychiat., 2001, 25, 767-780. (Pubitemid 32374966)
124. Schiepers, O.J.G.; Wichers, M.C.; Maes, M. Cytokine and major depression. Prog. Neuro-Psychopharmacol. Biol. Psychiat., 2005, 29, 201-217.
125. Moreau, A.; Vilarem, M.J.; Maurel, P.; Pascussi, J.M. Xenoreceptors CAR and PXR activation and consequence on lipid metabolism, glucose homeostasis, and inflammatory response. Mol. Pharmaceut., 2008, 5, 35-41. (Pubitemid 351300032)
126. Warren, G.W.; Poloyac, S.M.; Gary, D.S.; Mattson, M.P.; Blouin, R.A. Hepatic cytochrome P-450 expression in tumor necrosis factor- alpha receptor (p55/p75) knockout mice after endotoxin administration. J. Pharmacol. Exp. Ther., 1999, 288, 945-950. (Pubitemid 29254130)
127. Siewert, E.; Bort, R., Kluge, R.; Heinrich, P.C.; Castell, J.; Jover, R. Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent. Hepatology, 2000, 32, 49-55. (Pubitemid 30432365)
128. Tinel, M.; Elkahwaji, J.; Robin, M.A.; Fardel, N.; Descatoire, V.; Haouzi, D.; Berson, A.; Pessayre, D. Interleukin-2 overexpresses cmyc and down-regulates cytochrome P-450 in rat hepatocytes. J. Pharmacol. Exp. Ther., 1999, 289, 649-655. (Pubitemid 29191214)
129. Bleu, A.M.; Maurel, P.; Pichette, V.; Leblond, F.; du Suich, P. Interleukin-1ř, interleukin-6, tumor necrosis factor-ř and interferon- ř released by viral infection and aseptic inflammation reduce CYP1A1, 1A2 and 3A6 expression in rabbit hepatocytes. Eur. J. Pharmacol., 2003, 473, 197-206. (Pubitemid 36929885)
130. Pascussi, J.M.; Gerbal-Chaloin, S.; Pichard-Garcia, L.; Daujat, M.; Fabre, J.M.; Maurel, P.; Vilarem, M.J. Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochem. Biophys. Res. Commun., 2000, 274, 707-713. (Pubitemid 30663683)
131. Assenat, E.; Gerbal-Chaloin, S.; Larrey, D.; Saric, J.; Fabre, J.M.; Maurel, P.; Vilarem, M.J.; Pascussi, J.M. Interleukin 1ř inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. Hepatology, 2004, 40, 951-960. (Pubitemid 39288129)
132. Beigneux, A.P.; Moser, A.H.; Shigenaga, J.K.; Grunfeld, C.; Feingold, K.R. The acute phase response is associated with retinoid X receptor repression in rodent liver. J. Biol. Chem., 2000, 275, 16390-16399. (Pubitemid 30366957)
133. Fang, C.; Yoon, S.; Tinberg.; Jarvelainen, H.A.; Lindros, K.O.; Ingelman-Sundberg, M. Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure. Biochem. Pharmacol., 2004, 67, 1389-1397. (Pubitemid 38315104)
134. Liptrott, N.J.; Penny, M.; Bray, P.G.; Sathish, J.; Khoo, S.H.; Back, D.J.; Owen, A. The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC. Br. J. Pharmacol., 2009, 156, 497-508.
135. Zídek, Z.; Anzenbacher, P.; Kmonířková, E. Current status and challenges of cytokine pharmacology. Br. J. Pharmacol., 2009, 157, 342-361.
136. Wójcikowski, J.; Daniel, W.A. The brain dopaminergic system as an important center regulating liver cytochrome P450 in the rat. Expert Opin. Drug Metab. Toxicol., 2009, 5, 631-645.
137. Wójcikowski, J.; Gořembiowska, K.; Daniel, W.A. The regulation of liver cytochrome P450 by the brain dopaminergic system. Curr. Drug Metab., 2007, 8, 631-638. (Pubitemid 47209100)
138. Wójcikowski, J.; Daniel W.A. Identification of factors mediating the effects of the brain dopaminergic system on the expression of cytochrome P450 in the liver. Pharmacol. Rep., 2008, 60, 966-971.
139. Wójcikowski, J.; Gořembiowska, K.; Daniel W.A. Regulation of liver cytochrome P450 by activation of brain dopaminergic system: Physiological and pharmacological implications. Biochem. Pharmacol., 2008, 76, 258-267.
140. Murayama, N.; Shimada, M.; Yamazoe, Y.; Kato, R. Difference in the susceptibility of two phenobarbital-inducible forms, P450IIB1 and P450IIB2, to thyroid hormone- and growth hormone-induced suppression in rat liver: Phenobarbital-inducible P450IIB2 suppression by thyroid hormone acting directly, but not through the pituitary system. Mol. Pharmacol., 1991, 39, 811-817.
141. Vrzal, R.; Ulrichova, J.; Dvorak, Z. Aromatic hydrocarbon receptor status in the metabolism of xenobiotics under normal and pathophysiological conditions. Biomed. Papers, 2004, 148, 3-10.
142. Sérée, E.; Villard, P.H.; Pascussi, J.M.; Pineau, T.; Maurel, P.; Nguyen, Q.B.; Fallone, F.; Martin, P.M.; Champion, S.; Lacarelle, B.; Savouret, J.F.; Barra, Y. Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites. Gastroenterology, 2004, 127, 1436-1445. (Pubitemid 39457770)
143. Hunter, J.; Kassam, A.; Winrow, C.J.; Rachubinski, R.A.; Capone, J.P. Crosstalk between the thyroid hormone and peroxisome proliferator- activated receptors in regulating peroxisome proliferatorresponsive genes. Mol. Cell Endocrinol., 1996, 116, 213-221. (Pubitemid 26052798)
144. Miller, R.T.; Scappino, L.A.; Long, S.M.; Corton, J.C. Role of thyroid hormones in hepatic effects of peroxisome proliferators. Toxicol. Pathol., 2001, 29, 149-155. (Pubitemid 32127334)
145. Konstandi, M.; Johnson, E.O.; Marselos, M.; Kostakis, D.; Fotopoulos, A.; Lang, M.A. Stress-mediated modulation of B(ř)Pinduced hepatic CYP1A1: Role of catecholamines. Chemico-Biol. Interact., 2004, 147, 65-77. (Pubitemid 38076850)
146. Konstandi, M.; Kostakis, D.; Harkitis, P.; Marselos, M.; Johnson, E.O.; Adamidis, K; Lang, M.A. Role of adrenoceptor-linked signaling pathways in the regulation of CYP1A1 gene expression. Biochem. Pharmacol., 2005, 69, 277-287. (Pubitemid 41556574)
147. Konstandi, M.; Kostakis, D.; Harkitis, P.; Johnson, E.O.; Marselos, M.; Adamidis, K.; Lang, M.A. Benzo(ř)pyrene-induced upregulation of CYP1A2 gene expression: Role of adrenoceptorlinked signaling pathways. Life Sci., 2006, 79, 331-341. (Pubitemid 43817047)
148. Konstandi, M.; Lang, M.A.; Kostakis, D.; Johnson, E.O.; Marselos, M. Predominant role of peripheral catecholamines in the stressinduced modulation of CYP1A2 inducibility by benzo(ř)pyrene. Basic Clin. Pharmacol. Toxicol., 2007, 102, 35-44 (Pubitemid 350294082)
149. Kot, M.; Daniel, W.A. The brain noradrenergic and serotonergic systems as unknown factors regulating the activity of cytochrome P450. Eur. Neuropsychopharmacol., 2009, 19(Suppl 1), S17.
150. Sadakierska-Chudy, A.; Kot, M.; Haduch, A.; Gořembiowska, K.; Daniel, W.A. The role of the brain noradrenergic system in the regulation of cytochrome P450 expression in rat liver. Pharmacol. Rep., 2010, Suppl., 98-99.
151. Shimazu, T.; Ogasawara, S. Effects of hypothalamic stimulation of gluconeogenesis and glycolysis in rat liver. Am. J. Physiol., 1975, 228, 1787-1793.
152. Guellaen, G.; Yates-Aggerbeck, M.; Vauquelin, G.; Strosberg, D.; Hanoune, J. Characterization with [3H] dihydroergocryptine of the alpha-adrenergic receptor of the hepatic plasma membrane. Comparison with the beta-adrenergic receptor in normal and adrenalectomized rats. J. Biol. Chem., 1978, 253, 1114-1120. (Pubitemid 8288830)
153. Uyama, N.; Geerts, A.; Reynaert, H. Neural connections between the hypothalamus and the liver. Anat. Rec. A. Discov. Mol. Cell. Evol. Biol, 2004, 280, 808-820. (Pubitemid 39330960)
154. Oesch-Bartlomowicz, B.; Huelster, A.; Wiss, O.; Antoniou-Lipfert, P.; Dietrich, C.; Arand, M.; Weiss, C.; Bockamp, E.; Oesch, F. Aryl hydrocarbon receptor activation by cAMP vs. dioxin: Divergent signaling pathways. Proc. Natl. Acad. Sci. USA, 2005, 102, 9218-9223. (Pubitemid 40923544)
155. Oesch-Bartlomowicz, B.; Oesch, F. Fast regulation of cytochrome P450 activities by phosphorylation and consequences for drug metabolism and toxicity. Biol. Chem., 2002, 383, 1587-1592. (Pubitemid 35282978)
156. Paramonova, G.I. Effect of denervation of the liver on the system of microsomal oxidation in adult and old rats. Fiziol. Zh., 1990, 36, 84-89.
157. Aschirmetow, A.K.; Krakovski, M.E. The role of the parasympathetic nervous system in the regulation of microsomal monooxygenase activity in the liver of rats. Fiziol. Zh., 1990, 36, 43-46.
158. Klinger, W.; Karge, E.; Danz, M.; Krug, M. Nerval influences on liver cytochrome P450. Exp. Toxic. Pathol., 1995, 47, 299-303.
159. Ruddell, R.G.; Mann, D.A.; Ramm, G.A. The function of serotonin within the liver. J. Hepatol., 2008, 48, 666-675.
160. Kaiser, C.; Jain, T. Dopamine receptors: Functions, subtypes and emerging concepts. Med. Res. Rev., 1985, 5, 145-229. (Pubitemid 15145074)
161. Zeng, C; Zhang, M; Asico, LD; Eisner, G.M.; Jose, P.A. The dopaminergic system in hypertension. Clin. Sci., 2007, 112, 583-597. (Pubitemid 46849549)
162. Hiroi, T.; Imaoka, S.; Funae, Y. Dopamine formation from tyramine by CYP2D6. Biochem. Biophys. Res. Commun., 1998, 249, 838-843. (Pubitemid 28441925)
163. Bromek, E.; Haduch, A.; Daniel, W.A. The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study. Eur. J. Pharmacol., 2010, 626, 171-178.
164. Eisenhofer, G.; Aneman, A.; Friberg, P.; Hooper, D.; Fandriks, L.; Lonroth, H.; Hunyady, B.; Mezey, E. Substantial production of dopamine in the human gastrointestinal tract. J. Clin. Endocrinol. Metab., 1997, 82, 3864-3871. (Pubitemid 27509384)
165. Konstandi, M.; Harkitis, P.; Kostakis, D.; Marselos, M.; Johnson, E.O.; Lang, M.A. D2-receptor-linked signaling pathways regulate the expression of hepatic CYP2E1. Life Sci., 2008, 82, 1-10. (Pubitemid 350251388)
166. Bergmann, M.; Sautner, T. Immunomodulatory effects of vasoactive catecholamines. Wien Klein. Wochenschr., 2002, 144, 752-761.
167. Besser, M.J.; Ganor, Y.; Levite, M. Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFř or both. J. Neuroimmunol., 2005, 169, 161-171. (Pubitemid 41528789)
168. Daniel, W.A. The influence of long-term treatment with psychotropic drugs on cytochrome P450: The involvement of different mechanisms. Expert Opin. Drug. Metab. Toxicol., 2005, 1, 203-217.
169. Murray, M. Inhibition and induction of cytochrome P450 2B1 in rat liver by promazine and chlorpromazine. Biochem. Pharmacol., 1992, 44, 1219-1222.
170. Rane, A.; Liu, Z.; Levol, R.; Bjelfman, C.; Thyr, C.; Ericson, H.; Hansson, T.; Henderson, C.; Wolf, C.R. Differential effects of neuroleptic agents on hepatic cytochrome P-450 isoenzymes in the male rat. Biochim. Biophys. Acta, 1996, 1291, 60-66. (Pubitemid 26284326)
171. Tateishi, T.; Kumai, T.; Watanabe, M.; Tanaka, M.; Kobayashi, S. A comparison of the effect of five phenothiazines on hepatic CYP isoenzymes in rats. Pharmacol. Toxicol., 1999, 85, 252-256.
172. Daniel, W.A.; Haduch, A.; Syrek, M.; Boksa, J. Direct and indirect interactions between antidepressant drugs and CYP2C6 in the rat liver during long-term treatment. Eur. Neuropsychopharmacol., 2006, 16, 580-587. (Pubitemid 44716661)
173. Haduch, A.; Wójcikowski, J.; Daniel, W. A. The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3A. Eur. Neuropsychopharmacol., 2006, 16, 178-186. (Pubitemid 43358008)
174. Haduch, A.; Wójcikowski, J.; Daniel, W. A. The effect of selected antidepressant drugs on cytochrome P450 2B (CYP2B) in rat liver. An in vitro and in vivo study. Pharmacol. Rep., 2008, 60, 957-965.
175. Kot, M.; Wójcikowski J.; Daniel, W.A. Caffeine metabolism during prolonged treatment of rats with antidepressant drugs. Pharmacol. Rep., 2007, 59, 727-33. (Pubitemid 351586565)
176. Warrington, S.J. Clinical implications of the pharmacology of serotonin reuptake inhibitors. Int. Clin. Psychopharmacol., 1992, 7, 13-19. (Pubitemid 23011269)
177. O'Malley, K.; Braunung, M.; Stevenson, I.; Turnbull, M.J. Stimulation of drug metabolism in man by tricyclic antidepressants. Eur. J. Clin. Pharmacol., 1973, 6, 102-106.
178. Cresteil, T.; Celier, C.; Kremers, P.; Flinois, J.P.; Beaune, P.H; Leroux, JP. Induction of drug metabolizing enzymes by tricyclic antidepressants in human liver: Characterization and partial resolution of cytochrome P-450. Br. J. Clin. Pharmacol., 1983, 1, 651-657. (Pubitemid 14208202)
179. Meltzer, H.Y. Long-term effects of neuroleptic drugs on the neuroendocrine system. Adv. Biochem. Psychopharmacol., 1985, 40, 59-68.